SE9301830D0
(sv)
*
|
1993-05-28 |
1993-05-28 |
Ab Astra |
New compounds
|
US6875872B1
(en)
|
1993-05-28 |
2005-04-05 |
Astrazeneca |
Compounds
|
SE504459C2
(sv)
*
|
1994-07-15 |
1997-02-17 |
Astra Ab |
Förfarande för framställning av substituerade sulfoxider
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
SE510650C2
(sv)
|
1997-05-30 |
1999-06-14 |
Astra Ab |
Ny förening
|
US6747155B2
(en)
|
1997-05-30 |
2004-06-08 |
Astrazeneca Ab |
Process
|
SE510643C2
(sv)
*
|
1997-06-27 |
1999-06-14 |
Astra Ab |
Termodynamiskt stabil omeprazol natrium form B
|
SK179899A3
(en)
|
1997-07-03 |
2001-12-03 |
Du Pont Pharm Co |
Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
|
US6096340A
(en)
*
|
1997-11-14 |
2000-08-01 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
SE9704183D0
(sv)
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New process
|
US6174548B1
(en)
|
1998-08-28 |
2001-01-16 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
AU742620B2
(en)
*
|
1998-01-30 |
2002-01-10 |
Sepracor, Inc. |
R-lansoprazole compositions and methods
|
AU3967399A
(en)
*
|
1998-04-30 |
1999-11-16 |
Sepracor, Inc. |
S-rabeprazole compositions and methods
|
CA2330139A1
(en)
*
|
1998-04-30 |
1999-11-04 |
Sepracor Inc. |
R-rabeprazole compositions and methods
|
US6365589B1
(en)
|
1998-07-02 |
2002-04-02 |
Bristol-Myers Squibb Pharma Company |
Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
|
US6733778B1
(en)
|
1999-08-27 |
2004-05-11 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
CN1087739C
(zh)
*
|
1998-12-28 |
2002-07-17 |
中国科学院成都有机化学研究所 |
光学纯的苯并咪唑类抗消化性溃疡药物的包结拆分制备法
|
SE9900274D0
(sv)
*
|
1999-01-28 |
1999-01-28 |
Astra Ab |
New compound
|
TWI289557B
(en)
|
1999-06-17 |
2007-11-11 |
Takeda Chemical Industries Ltd |
A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
|
EP1191025B1
(en)
|
1999-06-30 |
2005-06-22 |
Takeda Pharmaceutical Company Limited |
Crystals of lansoprazole
|
WO2001014366A1
(fr)
*
|
1999-08-25 |
2001-03-01 |
Takeda Chemical Industries, Ltd. |
Procede de preparation de derives optiquement actifs de sulfoxyde
|
US6262085B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6780880B1
(en)
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6316020B1
(en)
*
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
ES2273829T3
(es)
*
|
2000-04-28 |
2007-05-16 |
Takeda Pharmaceutical Company Limited |
Procedimiento para producir derivado de sulfoxido opticamente activo.
|
ES2293988T3
(es)
*
|
2000-05-15 |
2008-04-01 |
Takeda Pharmaceutical Company Limited |
Procedimiento para producir un cristal.
|
KR100869677B1
(ko)
|
2000-05-15 |
2008-11-21 |
다케다 야쿠힌 고교 가부시키가이샤 |
결정의 제조방법
|
JP5412023B2
(ja)
*
|
2000-08-04 |
2014-02-12 |
武田薬品工業株式会社 |
ベンズイミダゾール化合物の塩およびその用途
|
HU229356B1
(en)
*
|
2000-12-01 |
2013-11-28 |
Takeda Pharmaceutical |
Process for the crystallization of (r)- or (s)-lansoprazole
|
AU2002338655A1
(en)
*
|
2001-04-13 |
2002-10-28 |
Aspinterm Llc |
Methods of preparing sulfinamide and sulfoxides
|
GB2376231A
(en)
*
|
2001-06-06 |
2002-12-11 |
Cipla Ltd |
Benzimidazole-cyclodextrin inclusion complex
|
EP1469839A2
(en)
*
|
2002-01-25 |
2004-10-27 |
Santarus, Inc. |
Transmucosal delivery of proton pump inhibitors
|
WO2003074514A1
(en)
|
2002-03-05 |
2003-09-12 |
Astrazeneca Ab |
Alkylammonium salts of omeprazole and esomeprazole
|
AU2003262375A1
(en)
*
|
2002-04-22 |
2003-11-03 |
Sun Pharmaceutical Industries Limited |
Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts
|
EP1515963B1
(en)
*
|
2002-06-27 |
2007-02-14 |
Dr. Reddy's Laboratories Ltd. |
A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
|
CA2502219C
(en)
*
|
2002-10-16 |
2012-05-29 |
Takeda Pharmaceutical Company Limited |
A process for producing an amorphous isomer of lansoprazole
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
BR0315574A
(pt)
|
2002-10-22 |
2005-09-20 |
Ranbaxy Lab Ltd |
Forma amorfa de esomeprazol, composição farmacêutica contendo o mesmo e processo para sua preparação
|
DE10254167A1
(de)
|
2002-11-20 |
2004-06-09 |
Icon Genetics Ag |
Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
|
SI1575941T1
(sl)
*
|
2002-12-06 |
2012-08-31 |
Nycomed Gmbh |
Postopek za pripravo (S)-pantoprazola
|
DK1578742T3
(da)
*
|
2002-12-06 |
2013-01-21 |
Nycomed Gmbh |
Fremgangsmåde til fremstilling af optisk rene aktive forbindelser
|
US20060122233A1
(en)
*
|
2002-12-16 |
2006-06-08 |
Yatendra Kumar |
Rabeprazole calcium
|
FR2848555B1
(fr)
|
2002-12-16 |
2006-07-28 |
Negma Gild |
Enantiomere(-)du tenatoprazole et son application en therapeutique
|
JP2006514108A
(ja)
|
2002-12-19 |
2006-04-27 |
テバ ファーマシューティカル インダストリーズ リミティド |
パントプラゾールナトリウムの固体状態、それらの調製方法、及び公知のパントプラゾールナトリウム水和物の調製方法
|
CN1723208A
(zh)
*
|
2003-01-07 |
2006-01-18 |
兰贝克赛实验室有限公司 |
咪唑衍生物的镁盐
|
TWI367759B
(en)
*
|
2003-02-20 |
2012-07-11 |
Santarus Inc |
A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid
|
EP1606279A1
(en)
*
|
2003-02-28 |
2005-12-21 |
Ranbaxy Laboratories, Ltd. |
Polymorphs of s-omeprazole
|
EP1601667A2
(en)
*
|
2003-03-12 |
2005-12-07 |
Teva Pharmaceutical Industries Limited |
Crystalline and amorphous solids of pantoprazole and processes for their preparation
|
EP1611901B1
(en)
*
|
2003-03-13 |
2013-07-10 |
Eisai R&D Management Co., Ltd. |
Preventive or remedy for teeth grinding
|
JP2006523201A
(ja)
*
|
2003-03-28 |
2006-10-12 |
シデム ファーマ |
スルホキシド誘導体をエナンチオ選択的に調製する方法
|
FR2852956B1
(fr)
*
|
2003-03-28 |
2006-08-04 |
Negma Gild |
Procede de preparation enantioselective de derives de sulfoxydes
|
CN1842525A
(zh)
*
|
2003-05-05 |
2006-10-04 |
兰贝克赛实验室有限公司 |
苯并咪唑衍生物的钡盐
|
MXPA05013316A
(es)
|
2003-06-10 |
2006-03-17 |
Teva Pharma |
Proceso para preparar bencimidazoles 2[-(piridinil)metil]sulfinil-sustituidos y derivados clorados novedosos de pantoprazol.
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
SE0302382D0
(sv)
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts II
|
SE0302381D0
(sv)
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts I
|
AU2003288703A1
(en)
*
|
2003-12-05 |
2005-06-24 |
Hetero Drugs Limited |
A process for the preparation of substitited pyridinylmethylsulfinyl- benzimidazole enantiomers
|
SE0400410D0
(sv)
*
|
2004-02-20 |
2004-02-20 |
Astrazeneca Ab |
New compounds
|
PT1740571E
(pt)
|
2004-04-28 |
2009-09-02 |
Hetero Drugs Ltd |
Processo para preparar compostos de piridinilmetil-1hbenzimidazol na forma enantiomericamente enriquecida ou como enantiómeros únicos
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
EP1748998B1
(en)
*
|
2004-05-28 |
2010-01-27 |
Hetero Drugs Limited |
A novel stereoselective synthesis of benzimidazole sulfoxides
|
BRPI0511515A
(pt)
*
|
2004-06-02 |
2007-12-26 |
Altana Pharma Ag |
processo para a preparação de compostos de piridin-2-ilmetilsulfinil-1h-benzimidazol
|
JP5563735B2
(ja)
|
2004-06-16 |
2014-07-30 |
タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド |
Ppi多回剤形
|
US20080249134A1
(en)
*
|
2004-06-24 |
2008-10-09 |
Ursula Hohlneicher |
New Esomeprazole Sodium Salt Crystal Modification
|
CN1972928A
(zh)
*
|
2004-06-24 |
2007-05-30 |
阿斯利康(瑞典)有限公司 |
制备用于制备依美拉唑钠盐的结晶修饰物的新方法
|
FR2876101B1
(fr)
*
|
2004-10-05 |
2007-03-02 |
Sidem Pharma Sa Sa |
Procede de preparation enantioselective de derives de sulfoxydes
|
PL1802584T3
(pl)
*
|
2004-10-11 |
2010-03-31 |
Ranbaxy Laboratories Ltd |
Sposób wytwarzania podstawionych sulfotlenków
|
US7592111B2
(en)
*
|
2004-11-05 |
2009-09-22 |
Xerox Corporation |
Imaging member
|
WO2006099810A1
(en)
*
|
2005-03-25 |
2006-09-28 |
Livzon Pharmaceutical Group Inc. |
Substituted sulfoxide compounds, methods for preparing the same and use thereof
|
CN101098867B
(zh)
*
|
2005-03-25 |
2010-08-11 |
丽珠医药集团股份有限公司 |
取代的亚砜类化合物和其制备方法及用途
|
US20090298884A1
(en)
*
|
2005-05-06 |
2009-12-03 |
Glenmark Generics Ltd. |
Esomeprazole Strontium Salt, Process For Its Preparation and Pharmaceutical Compositions Containing Same
|
ES2432563T3
(es)
*
|
2005-06-08 |
2013-12-04 |
Lek Pharmaceuticals D.D. |
Solvato cristalino de omeprazol sódico
|
US20070043085A1
(en)
*
|
2005-08-19 |
2007-02-22 |
Glenmark Pharmaceuticals Limited |
Process for the preparation of amorphous form of neutral esomeprazole
|
NZ568471A
(en)
*
|
2005-12-05 |
2010-09-30 |
Astrazeneca Ab |
New process for the preparation of esomeprazole non-salt form
|
DE102005061720B3
(de)
*
|
2005-12-22 |
2006-10-19 |
Ratiopharm Gmbh |
Enantioselektive Herstellung von Benzimidazolderivaten und ihren Salzen
|
EP1801110A1
(en)
|
2005-12-22 |
2007-06-27 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Esomeprazole arginine salt
|
US7553857B2
(en)
|
2005-12-23 |
2009-06-30 |
Lek Pharmaceuticals D.D. |
S-omeprazole magnesium
|
KR101289215B1
(ko)
|
2005-12-28 |
2013-07-29 |
유니온 퀴미코 파르마세우티카, 에스.에이. |
오메프라졸의 (에스)-엔안티오머의 제조 방법
|
CN1810803B
(zh)
*
|
2006-02-17 |
2010-11-17 |
中国科学院上海有机化学研究所 |
高对映体选择性制备(s)-奥美拉唑的方法
|
US7579476B2
(en)
*
|
2006-02-24 |
2009-08-25 |
Praktikatalyst Pharma, Llc |
Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
|
US8063074B2
(en)
*
|
2006-05-04 |
2011-11-22 |
Dr. Reddy's Laboratories Limited |
Polymorphic forms of esomeprazole sodium
|
US7786309B2
(en)
*
|
2006-06-09 |
2010-08-31 |
Apotex Pharmachem Inc. |
Process for the preparation of esomeprazole and salts thereof
|
JP2009542624A
(ja)
|
2006-07-05 |
2009-12-03 |
ルピン・リミテッド |
スルホキシド化合物の光学的に純粋な又は光学的に富化されたエナンチオマーの調製方法
|
WO2008018091A1
(en)
*
|
2006-08-08 |
2008-02-14 |
Jubilant Organosys Limited |
Process for producing sulphoxide compounds
|
JP2009196894A
(ja)
*
|
2006-10-13 |
2009-09-03 |
Eisai R & D Management Co Ltd |
スルフィニルベンズイミダゾール化合物またはその塩の製造方法
|
JP5492417B2
(ja)
|
2006-10-13 |
2014-05-14 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
胃酸分泌抑制作用を有するベンズイミダゾール化合物
|
EP1947099A1
(en)
|
2007-01-18 |
2008-07-23 |
LEK Pharmaceuticals D.D. |
Process for solvent removal from omeprazole salts
|
AU2008217603C1
(en)
|
2007-02-21 |
2013-08-15 |
Cipla Limited |
Process for the preparation of esomeprazole magnesium dihydrate
|
ATE534643T1
(de)
*
|
2007-06-07 |
2011-12-15 |
Aurobindo Pharma Ltd |
Verbessertes verfahren zur herstellung eines optisch aktiven protonenpumpenhemmers
|
CN101323609B
(zh)
*
|
2007-06-15 |
2013-05-01 |
成都福瑞生物工程有限公司 |
不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法
|
WO2009066321A2
(en)
*
|
2007-10-03 |
2009-05-28 |
Ipca Laboratories Limited |
Process for optically active sulfoxide compounds
|
US8106210B2
(en)
|
2007-10-08 |
2012-01-31 |
Hetero Drugs Limited |
Polymorphs of esomeprazole salts
|
KR20170097787A
(ko)
|
2007-10-12 |
2017-08-28 |
다케다 파마슈티칼스 유에스에이, 인코포레이티드 |
음식 섭취와 관계없이 위장 장애를 치료하는 방법
|
FR2925899B1
(fr)
*
|
2007-12-27 |
2012-12-21 |
Sidem Pharma Sa |
Procede de preparation enantioselective de sulfoxydes.
|
CN101492459B
(zh)
*
|
2008-01-25 |
2011-04-27 |
山东轩竹医药科技有限公司 |
含烷氧乙酰基二氢异噁唑并吡啶化合物
|
CN101497603B
(zh)
*
|
2008-01-30 |
2012-11-07 |
山东轩竹医药科技有限公司 |
含有被烷氧烷胺氧基取代的吡啶的苯并咪唑衍生物
|
PE20091680A1
(es)
|
2008-03-10 |
2009-11-16 |
Takeda Pharmaceutical |
Cristal de compuestos de bencimidazol
|
MX2010010049A
(es)
*
|
2008-03-18 |
2010-10-04 |
Reddys Lab Ltd Dr |
Proceso y polimorfos de dexlansoprazol.
|
CN101538264A
(zh)
*
|
2008-03-19 |
2009-09-23 |
中国科学院成都有机化学有限公司 |
手性亚砜类化合物的制备新方法
|
WO2009145368A1
(en)
*
|
2008-05-27 |
2009-12-03 |
Sk Chemicals Co., Ltd. |
Improved preparing method of (s)-omeprazole from omeprazole racemate using optical resolution agent
|
EP2143722A1
(en)
|
2008-07-09 |
2010-01-13 |
Lek Pharmaceuticals D.D. |
Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
|
WO2010039885A2
(en)
*
|
2008-09-30 |
2010-04-08 |
Teva Pharmaceutical Industries Ltd. |
Crystalline forms of dexlansoprazole
|
EP2264024A1
(en)
|
2008-10-14 |
2010-12-22 |
LEK Pharmaceuticals d.d. |
Process for the preparation of enantiomerically enriched proton pump inhibitors
|
IT1391776B1
(it)
|
2008-11-18 |
2012-01-27 |
Dipharma Francis Srl |
Procedimento per la preparazione di dexlansoprazolo
|
CZ200990A3
(cs)
*
|
2009-02-16 |
2010-08-25 |
Zentiva, K.S. |
Zpusob výroby (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolu
|
WO2010097583A1
(en)
|
2009-02-24 |
2010-09-02 |
Cipla Limited |
Esomeprazole potassium polymorph and its preparation
|
CZ2009172A3
(cs)
*
|
2009-03-17 |
2010-09-29 |
Zentiva, K.S. |
Zpusob výroby (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolu
|
WO2010150276A2
(en)
*
|
2009-06-02 |
2010-12-29 |
Sun Pharmaceutical Industries Limited |
Process for preparing sulphoxide compounds
|
IT1395118B1
(it)
|
2009-07-29 |
2012-09-05 |
Dipharma Francis Srl |
Procedimento per la preparazione di dexlansoprazolo cristallino
|
WO2011058569A1
(en)
|
2009-11-12 |
2011-05-19 |
Hetero Research Foundation |
Process for the resolution of omeprazole
|
WO2011092665A1
(en)
|
2010-01-29 |
2011-08-04 |
Ranbaxy Laboratories Limited |
Process for the preparation of crystalline forms of dexlansoprazole
|
WO2011161421A1
(en)
|
2010-06-24 |
2011-12-29 |
Cipla Limited |
Salts and polymorphs of dexrabeprazole
|
CN101914090B
(zh)
*
|
2010-08-13 |
2013-03-20 |
埃斯特维华义制药有限公司 |
左旋奥美拉唑的制备方法
|
CN102558150B
(zh)
*
|
2010-12-31 |
2014-03-12 |
正大天晴药业集团股份有限公司 |
取代亚砜化合物的合成方法
|
CN102321071B
(zh)
*
|
2011-07-20 |
2013-01-23 |
江苏奥赛康药业股份有限公司 |
一种高纯度埃索美拉唑钠的工业化生产方法
|
CN102977076A
(zh)
*
|
2011-09-02 |
2013-03-20 |
扬子江药业集团上海海尼药业有限公司 |
一种右兰索拉唑的制备方法
|
CN102329302A
(zh)
*
|
2011-10-22 |
2012-01-25 |
刘强 |
一种埃索美拉唑及其盐的制备方法
|
CN102408412A
(zh)
*
|
2011-10-25 |
2012-04-11 |
广东华南药业集团有限公司 |
高对映体选择性制备(s)- 奥美拉唑的方法
|
CN102432412A
(zh)
*
|
2011-10-28 |
2012-05-02 |
成都欣捷高新技术开发有限公司 |
一种手性亚砜类质子泵抑制剂或其可药用盐的制备方法
|
KR101300950B1
(ko)
*
|
2011-10-31 |
2013-08-27 |
르노삼성자동차 주식회사 |
전기자동차의 공기 흡입 장치
|
WO2013140120A1
(en)
|
2012-03-22 |
2013-09-26 |
Cipla Limited |
Glycerol solvate forms of (r) - 2 - [ [ [3 -methyl -4 (2,2, 2 - trifluoroethoxy) pyridin- 2 - yl] methyl] sulphinyl] - 1h - ben zimidazole
|
CN102633776B
(zh)
*
|
2012-03-28 |
2014-06-18 |
中山市仁合药业有限公司 |
一种埃索美拉唑及其钠盐的制备方法
|
CN102659763B
(zh)
*
|
2012-04-27 |
2014-01-22 |
南京优科生物医药研究有限公司 |
一种右旋兰索拉唑合成与纯化的方法
|
CN103044402B
(zh)
*
|
2012-12-31 |
2015-01-14 |
康普药业股份有限公司 |
埃索美拉唑钠合成生产方法
|
CN103113351B
(zh)
*
|
2013-03-08 |
2015-01-21 |
苏州特瑞药业有限公司 |
一种光学纯手性亚砜类化合物的制备方法
|
CN104177336A
(zh)
*
|
2013-05-28 |
2014-12-03 |
上海汇伦生命科技有限公司 |
一种对映选择性合成右兰索拉唑的方法
|
WO2015155307A1
(en)
|
2014-04-11 |
2015-10-15 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical combinations of rivaroxaban and proton pump inhibitors
|
EP2933002A1
(en)
|
2014-04-11 |
2015-10-21 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Pharmaceutical combinations of dabigatran and proton pump inhibitors
|
EP2980086B1
(en)
|
2014-07-29 |
2016-06-15 |
F.I.S.- Fabbrica Italiana Sintetici S.p.A. |
Efficient process for the preparation of esomeprazole (S)-binol complex
|
KR20170098843A
(ko)
|
2014-12-26 |
2017-08-30 |
고쿠리츠다이가쿠호우진 도쿄다이가쿠 |
광학 활성의 프로톤 펌프 저해 화합물의 제조 방법
|
CN104610226A
(zh)
*
|
2014-12-31 |
2015-05-13 |
广东东阳光药业有限公司 |
一种右兰索拉唑的不对称氧化方法
|
ES2615637T3
(es)
*
|
2015-03-06 |
2017-06-07 |
F.I.S.- Fabbrica Italiana Sintetici S.P.A. |
Procedimiento mejorado para la purificación óptica del esomeprazol
|
CN105218392B
(zh)
*
|
2015-07-09 |
2017-11-21 |
天津青松华药医药有限公司 |
D‑酒石酸单酯单酰胺类化合物
|
CN105218391B
(zh)
*
|
2015-07-09 |
2017-11-21 |
天津青松华药医药有限公司 |
L‑酒石酸单酯单酰胺类化合物
|
CN105968097B
(zh)
*
|
2016-05-17 |
2019-05-03 |
杭州华东医药集团新药研究院有限公司 |
左旋泮托拉唑的工业化生产方法
|
CN106083818A
(zh)
*
|
2016-06-08 |
2016-11-09 |
扬子江药业集团有限公司 |
一种高纯度埃索美拉唑钠的制备方法
|
CN106366070B
(zh)
*
|
2016-08-10 |
2019-06-11 |
上海万巷制药有限公司 |
一种高纯度埃索美拉唑钠的制备方法
|
CN106632248A
(zh)
*
|
2016-09-30 |
2017-05-10 |
青岛云天生物技术有限公司 |
一种左旋泮托拉唑钠的制备工艺
|
CN106632249A
(zh)
*
|
2016-09-30 |
2017-05-10 |
青岛云天生物技术有限公司 |
一种制备(s)‑泮托拉唑钠的方法
|
CN106866630B
(zh)
*
|
2017-04-01 |
2018-08-07 |
上海华源医药科技发展有限公司 |
一种右兰索拉唑的制备方法
|
CN110746428A
(zh)
*
|
2019-10-29 |
2020-02-04 |
株洲千金药业股份有限公司 |
一种r型手性亚砜类化合物的制备方法
|
CN110698482A
(zh)
*
|
2019-10-29 |
2020-01-17 |
株洲千金药业股份有限公司 |
一种s型手性亚砜类化合物的制备方法
|
CN113845510A
(zh)
*
|
2020-06-27 |
2021-12-28 |
鲁南制药集团股份有限公司 |
一种埃索美拉唑的制备方法
|